Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

The following is a summary of "A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study," ...

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...

In 2006 Professor Yamanaka Shin’ya of Kyoto University published a paper reporting his success in producing induced pluripotent stem ... provides iPS cells for clinical use. Producing iPS cells from a ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Locke, MD, explains how cema-cel is genetically engineered for patient benefit. ALPHA [NCT03939026] and ALPHA2 [NCT04416984] are single-arm, multicenter, open-label phase 1 studies designed to test ...